The inhibition of noscapine to CYP3A4 and CYP2C9: explanation for clinical DDI between noscapine and warfarin

被引：0
|
作者：
Fang, Zhong-Ze [1 ]
Yang, Ling [1 ]
机构：
[1] Chinese Acad Sci, Dalian Inst Chem Phys, Lab Pharmaceut Resource Discovery, Dalian 116023, Peoples R China
来源：
DRUG METABOLISM REVIEWS | 2009年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
150
引用
收藏
页码：74 / 74
页数：1
相关论文
共 50 条
  • [1] Time-dependent inhibition (TDI) of CYP3A4 and CYP2C9 by noscapine potentially explains clinical noscapine-warfarin interaction
    Fang, Zhong-Ze
    Zhang, Yan-Yan
    Ge, Guang-Bo
    Huo, Hong
    Liang, Si-Cheng
    Yang, Ling
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 69 (02) : 193 - 199
  • [2] Inhibition of CYP3A4 and CYP2C9 by podophyllotoxin: Implication for clinical drug–drug interactions
    Jin-Hui Song
    Dong-Xue Sun
    Bin Chen
    Dai-Hong Ji
    Jie Pu
    Jie Xu
    Feng-De Tian
    Lin Guo
    Journal of Biosciences, 2011, 36 : 879 - 885
  • [3] Inhibition of CYP3A4 and CYP2C9 by podophyllotoxin: Implication for clinical drug-drug interactions
    Song, Jin-Hui
    Sun, Dong-Xue
    Chen, Bin
    Ji, Dai-Hong
    Pu, Jie
    Xu, Jie
    Tian, Feng-De
    Guo, Lin
    JOURNAL OF BIOSCIENCES, 2011, 36 (05) : 879 - 885
  • [4] The Relationship Between Warfarin Resistance and CYP2C9*2 and CYP2C9*3 Variations
    Kirac, Deniz
    Yaman, Aysun Erdem
    Doran, Tansu
    Altunok, Elif Cigdem
    MEDICAL JOURNAL OF BAKIRKOY, 2021, 17 (03) : 209 - 213
  • [5] Characterization of type II ligands in CYP2C9 and CYP3A4
    Ahlstrom, Marie M.
    Zamora, Ismael
    JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (06) : 1755 - 1763
  • [6] The involvement of CYP3A4 and CYP2C9 in the metabolism of 17α-ethinylestradiol
    Wang, B
    Sanchez, RI
    Franklin, RB
    Evans, DC
    Huskey, SEW
    DRUG METABOLISM AND DISPOSITION, 2004, 32 (11) : 1209 - 1212
  • [7] Dicloxacillin induces CYP2C19, CYP2C9 and CYP3A4 in vivo and in vitro
    Stage, Tore Bjerregaard
    Graff, Magnus
    Wong, Susan
    Rasmussen, Louise Ladebo
    Nielsen, Flemming
    Pottegard, Anton
    Brosen, Kim
    Kroetz, Deanna L.
    Khojasteh, Cyrus
    Damkier, Per
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 84 (03) : 510 - 519
  • [8] Clinically Significant CYP2C Inhibition by Noscapine but Not by Glucosamine
    Rosenborg, S.
    Stenberg, M.
    Otto, S.
    Ostervall, J.
    Masquelier, M.
    Yue, Q-Y
    Bertilsson, L.
    Eliasson, E.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 88 (03) : 343 - 346
  • [9] Effects of daily ingestion of cranberry juice on the pharmacokinetics of warfarin, tizanidine, and midazolam - Probes of CYP2C9, CYP1A2, and CYP3A4
    Lilja, J. J.
    Backman, J. T.
    Neuvonen, P. J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 (06) : 833 - 839
  • [10] Implications of In Vitro System Conditions for CYP2C9 and CYP3A4: Impact of pH on Clearance and Enzyme Inhibition
    Rougee, Luc R. A.
    Mohutsky, Michael A.
    Bedwell, David W.
    Ruterbories, Kenneth J.
    Hall, Stephen D.
    FASEB JOURNAL, 2016, 30
12345